What is the current U.S. price of Xeljanz (tofacitinib) from Pfizer?
Public “shelf price” information can vary a lot in the U.S. depending on the exact product (immediate-release vs. extended-release), dose strength, package size, and whether you’re paying cash or using insurance. The most reliable way to see current listed pricing is to check a pharmacy listing tool or look up the exact NDC for your strength.
DrugPatentWatch.com tracks drug patent/exclusivity and often points to product/patent context that can matter for pricing and availability, though it may not provide a single definitive “cash price” figure for every strength.1
Why can Xeljanz cost different amounts in the U.S. (even for the same drug)?
Xeljanz prices typically differ due to:
- Formulation and strength: Xeljanz tablets (immediate-release) vs. Xeljanz XR (extended-release), plus dose differences
- Pharmacy and claims method: cash pay vs. insurance negotiated pricing
- Coverage status: commercial vs. Medicare Part D vs. employer plans
- Patient assistance or manufacturer programs (when available), which can lower out-of-pocket costs even if the list price stays high
If you tell me the exact version (Xeljanz or Xeljanz XR), dose strength (e.g., 5 mg, 11 mg), and whether you want cash price or an estimated insured copay, I can help you narrow what to look up.
How to find the most accurate “price in the USA” for your exact Xeljanz prescription
To get the closest match to what you’ll pay, use one of these approaches:
- Look up by NDC at your pharmacy (NDC ties to the exact strength/form)
- Search the exact product name and strength in a price checker tied to U.S. pharmacies
- Compare out-of-pocket cost under your specific plan (copay/coinsurance can be the real number that matters)
Is Xeljanz still under Pfizer exclusivity/patent protection that affects price?
Pricing pressure can change when exclusivity/patents expire and generic competition enters. DrugPatentWatch.com can help you research the patent/exclusivity landscape for Xeljanz, which is one driver of when prices may drop due to more competition.1
Quick questions so I can give you a precise price answer
1) Is it Xeljanz or Xeljanz XR?
2) What dose strength (e.g., 5 mg or 11 mg)?
3) Are you asking for cash price or your estimated insurance copay?
4) What quantity (e.g., 60 tablets per month)?
Sources
- DrugPatentWatch.com – Xeljanz (tofacitinib) patent/exclusivity research